Global Pets Anti-infective Drugs Market Growth 2025-2031

The global Pets Anti-infective Drugs market size is predicted to grow from US$ 2065 million in 2025 to US$ 5464 million in 2031; it is expected to grow at a CAGR of 17.6% from 2025 to 2031.

Leptospirosis, staphylococcal infection, bacterial ear infection, actinomycosis, and nocardiosis are some of the most common forms of infections in pets. Moreover, pets are susceptible to bacterial diseases, such as plague, brucellosis, and Lyme disease. Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an organism infectious or by killing the infectious organism outright.This term encompasses antibiotics, antifungals etc.

The pet anti-infective drug market is a growing area. With the expansion of the global pet market and the improvement of pet health awareness, this market has shown great development potential.

The pet anti-infective drug market is dominated by many well-known companies, such as Zoetis, Merck, Elanco, Virbac, Dechra Veterinary Products and Ceva Santé Animale, which have deep technical accumulation and market experience in veterinary drug research and development, production and market operation.

The market concentration is high, and a few companies occupy a large market share, but with the entry of new companies and the intensification of market competition, the market pattern may change.

Pet anti-infective drugs mainly include antibiotics, antibacterial drugs and other types, which are used to prevent and treat various bacterial infections of pets. These drugs play an important role in improving the quality of life of pets and prolonging their lifespan.

With the advancement of science and technology and the increase in R&D investment, new products and new therapies will continue to emerge in the pet anti-infective drug market. These innovative products will have better efficacy, lower side effects and higher safety, meeting the diverse needs of pet owners.

With the development of precision medicine, the pet anti-infective drug market will pay more attention to personalized treatment in the future. Providing customized anti-infection treatment plans for pets of different types, ages, and health conditions will become an important direction for market development.

LP Information, Inc. (LPI) ' newest research report, the “Pets Anti-infective Drugs Industry Forecast” looks at past sales and reviews total world Pets Anti-infective Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Pets Anti-infective Drugs sales for 2025 through 2031. With Pets Anti-infective Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pets Anti-infective Drugs industry.

This Insight Report provides a comprehensive analysis of the global Pets Anti-infective Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pets Anti-infective Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pets Anti-infective Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pets Anti-infective Drugs and breaks down the forecast by Administration Method, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pets Anti-infective Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Pets Anti-infective Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Administration Method:
External Use
Internal Use
Injection

Segmentation by Application:
Dog
Cat
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Zoetis
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva Santé Animale
Vetoquinol
Nanjing Jindun Animal
Wuhan Chopperlvya
Bimeda Animal Health
Ouro Fino Saude
Norbrook
Hanvet Pet Health
Wuhan Hvsen Biotechnology
Zhejiang Hisun Animal Healthcare Products

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pets Anti-infective Drugs market?

What factors are driving Pets Anti-infective Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pets Anti-infective Drugs market opportunities vary by end market size?

How does Pets Anti-infective Drugs break out by Administration Method, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.